Ken Ohmachi

5PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 02, 2025
Final results of JCOG0601 randomized trial of R-CHOP versus CHOP combined with dose-dense rituximab for diffuse large B-cell lymphoma.

Ken Ohmachi, Tomohiro Kinoshita, Dai Maruyama

|Jul 22, 2024
Interim PET-guided ABVD or ABVD/escalated BEACOPP for newly diagnosed advanced-stage classic Hodgkin lymphoma (JCOG1305).

Shigeru Kusumoto, Wataru Munakata, Ryunosuke Machida

|May 26, 2023
Long-term follow-up after R-High CHOP/CHASER/LEED with Auto-PBSCT in untreated mantle cell lymphoma-Final analysis of JCOG0406.

Michinori Ogura, Kazuhito Yamamoto, Yasuo Morishima

|Mar 01, 2019
Phase I study of tirabrutinib (ONO-4059/GS-4059) in patients with relapsed or refractory B-cell malignancies in Japan.

Wataru Munakata, Kiyoshi Ando, Kiyohiko Hatake

|Jan 25, 2018
E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T-cell lymphoma: A phase I study.

Ken Ohmachi, Kiyoshi Ando, Michinori Ogura

Pageof 1

Frequent Collaborators

4 joint publications

Dai Maruyama

3 joint publications

Wataru Munakata

3 joint publications

Kana Miyazaki

2 joint publications

Kazuhito Yamamoto